Follow The Big Take Asia podcast today.After a years-long slump, Hong Kong’s IPO market is roaring back to life, thanks to a ...

At least two dozen Chinese companies have confidentially filed for listing in Hong Kong this year and more are preparing to ...

Ab&B Bio-Tech soared as much as 169% in its trading debut in Hong Kong, after retail investors flocked to the Chinese vaccine ...

STORY: From ether's appeal to Hong Kong's stablecoin frenzy... This is Crypto Weekly.:: Crypto Weekly:: Ether snapped upSome ...

The IPO rules guarantee institutional investors 40 per cent of the offering, while leaving as little as 10 per cent for ...

Bend Novatech Group Ltd's growth comes with high risks, rising costs, and valuation concerns. Click for more on the upcoming ...

The company plans to ship components made at its plant in Shenzhen to Hong Kong where robots for overseas clients would be ...

Management guided for an EBITDA margin of about 7% in FY26, with 100-150 bps expansion each year over the next four to five ...

Greater China emerges as key player, driven by Hong Kong’s resurgence and "shifting global capital flows toward Chinese ...

Under that scenario, Ab&B's price-to-sales (P/S) ratio would be as much as 21.5 times, far higher than for industry leaders.

Seven IPOs and two SPACs debuted this week, while five small IPOs and seven SPACs submitted initial filings. Read more here.